MorphoSys AG
MorphoSys AG (MOR) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · MOR · as of Sep 30, 2024
Ownership Breakdown
5
Institutional Holders
▼ 34 vs Q2
$2.53M
Total Inst. Value
▼ $19.21M vs Q2
602.60M
Shares Outstanding
freeFloat 0.15%
133,569
13F Shares Held
▼ 1.06M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
MOR largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
HENNION & WALSH ASSET MANAGEMENT, INC. pharmaceutical preparations | 123.3K | 8.19% | 8.19% | $2.34B | Oct 22, 2024 | ▼ 1.2K |
RHUMBLINE ADVISERS pharmaceutical preparations | 5.2K | 0.34% | 0.34% | $98.34M | Nov 12, 2024 | — held |
GAMMA INVESTING LLC pharmaceutical preparations | 4.1K | 0.27% | 0.27% | $77.58M | Oct 7, 2024 | ▲ 1.2K |
RONALD BLUE TRUST, INC. pharmaceutical preparations | 966 | 0.06% | 0.06% | $17.58M | Oct 17, 2024 | ▲ 875 |
BARCLAYS PLC pharmaceutical preparations | 14 | 0.00% | 0.00% | $1.03M | Mar 31, 2026 | NEW |
GOLDMAN SACHS GROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2024 | EXIT |
CITIGROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 12, 2024 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2024 | EXIT |
CSS LLC/IL pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2024 | EXIT |
NBC SECURITIES, INC. pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Oct 15, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
2
Increased
+2.1K shares1
New Positions
first time holders1
Decreased
−1.2K shares27
Sold Out
fully exitedNet shares change (top 50)
+858
+2.1K / −1.2K
Net new holders
-25
1 new / 27 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
MOR insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
MorphoSys AG (MOR) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 99.85%, while retail and public investors account for the remaining 0.13%.
The largest institutional shareholder of MorphoSys AG is HENNION & WALSH ASSET MANAGEMENT, INC., holding approximately 123,310 shares — equal to 8.19% of outstanding shares — as of September 30, 2024.
A total of 5 institutional investors currently hold MOR stock, with a combined institutional value of approximately $2,532,489 as of the most recent 13F filing period.
Frequently asked questions
MOR ownershipMorphoSys AG (MOR) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is HENNION & WALSH ASSET MANAGEMENT, INC. with a 8.19% stake. Company insiders hold 99.85%. Data sourced from SEC Form 13F as of September 30, 2024.